Jon Deleon Email & Phone Number

United States

Regional Sales Director, Central U.S. - Immunotherapy, Oncology & Urology♦ Leading a dedicated team of Strategic Account Managers (SAMs) across AL, MS, LA, AR, TN, KY, OH, PA, MI, IL, IN, MN, WI, NE, MO, KS, OK, and IA in both the institutional and clinic setting with call points in oncology and urology♦ Dedicated to improving the lives of men battling with advanced prostate cancer through appropriate use of PROVENGE (sipuleucel-T) Immunotherapy, a personalized cellular treatment made from a patient's own cells.♦ Working collaboratively with Dendreon's Medical, Nursing and Reimbursement partners to ensure favorable clinical and business outcomes for our providers and patients

Ga, Al, Ms, La, Fl, Sc

Ga, Al, Ms, La, Co

Hire and lead a Team of 6 Institutional Sales Specialists and 4 Professional Sales Specialists launching Nuzyra (i.e., omadacycline) in the institutional, out-patient infusion center, and clinic spaces. Indications for the launch included CABP and ABSSSIs. HCP call points include ID, Surgery, Pulmonology, Podiatry, ER, Hospitalists, and select IMs. Department call points include all the above with the addition of infection control, burn, trauma, pharmacy, purchasing, and C-suite.

Al, Fl, And Ms Gulf Coast

Hire and lead a team of cardiology / metabolic Specialty Sales Consultants launching the new cardiovascular risk reduction indication for Vascepa (icosapent ethyl). Call points include cardiology, endocrinology, and select IM physicians in both the Retail and Hospital settings.Accomplishments: - Led Team to a 40% increase in weekly TRX volume by the end of the 2nd quarter together.- Returned Team to pre-covid levels by the end of June 2021 finishing Q3 at 1 of 7 in the Area YTD

Western U.S.

Hire and lead a team of Health System Account Managers to launch Xtampza ER into the IDN space across the Midwest, South Central, and Western U.S. regions. Develop and implement solutions for which abuse-deterrent technology is appropriate for the institutional setting.Call points included C-Suite, Quality / Population Risk, Pharmacy and Supply Chain, Anesthesia, PM&R, inpatient Pain Services, Palliative Care, Oncology, as well a other specialties that would benefit from novel abuse deterrent opioid technologies.Accomplishments: - President's Club Award Trip 2017 - On track for President's Club Award Trip through Q3 2018*Recruited to Collegium Pharma (i.e.. Start-up based in Boston, MA) by my previous Sunovion Leadership that had already transitioned.

Al And Tn

Hire and lead a team of Therapeutic Specialists selling Sunovion's nebulized LABA arformoterol tartrate (i.e., Brovana) ,as well as the recently launched seizure medication eslicarbazebine acetate(i.e., Aptiom) in the AL / TN hospital, LTC, and office-based spaces. Call points included pulmonology , neurology, long-term care Directors, C-suite, and Durable Medical Equipment managers.Accomplishments: - Led team from 16 of 16 in the Nation to 9 of 16 during first full year

Fl And Ga

Hire and lead a team of Neuroscience Specialty Representatives to launch Merck's new "first in class"​ insomnia medication in the psychiatric and neurology space. Territory includes Florida and south Georgia.- Successfully completed the hiring of eleven Neuroscience Sales Representatives throughout FL and south GA.- Successfully completed all components of the "pre-launch"​ plan in preparation for the U.S. market introduction of Belsomra.- Appointed lead on national "vision" project by National Sales Director*Recruited by Sunovion Specialty Division (did not leave until all eleven Neuroscience Specialists where hired and on-boarded)

Gulf Coast (New Orleans, Baton Rouge, Mobile, Tallahassee, Jacksonville, Tampa)

First-line leader for the Gulf coast I-10 corridor markets.Responsibilities: Hire and lead a team of Women's Health Account Executives selling Myriad's line of molecular testing for hereditary cancer syndromes (i.e., HBOC and Lynch Syndrome) to OBGYN and imaging accounts.Accomplishments: Exceeded Q1 and Q2 FY2014 revenue targets by 700k and 930k respectively (fiscal year July - June).

Alabama

Responsibilities: Hire and lead sales team consisting of immunization sales specialist and immunization account managers in the state of AL to exceed company goals and meet GSK approved corporate objectives in both public and private immunization segments for both ped and adult franchise vaccine brands. ("Buy and bill" injectable)This role was preceded by multiple positions in sales leadership, training, and sales (i.e. institutional and retail) of increasing responsibility covering territories in TN / AL / MS / NC / VA / KY / LA. Therapeutic areas included: Oncology, Vaccines, CNS, neurology, Diabetes, Cardiovascular, Antibiotics, Women's Health, Urology, and Respiratory* President's Club Award trips as a leader: 2011, 2010, 2006, and 2004* Additional top 20% National finishes as a leader with no trip: 2007, 2005, and 2003* Market Development Manager rotation 2008